View Older Stories View More Recent Stories

Apr 22, 2026 05:09PM Boston Scientific (BSX) PT Lowered to $71 at Canaccord
Apr 22, 2026 04:41PM Boston Scientific (BSX) PT Lowered to $77 at Needham
Apr 22, 2026 04:03PM Boston Scientific (BSX) PT Lowered to $100 at RBC Capital
Apr 22, 2026 03:04PM Boston Scientific (BSX) PT Lowered to $100 at Jefferies
Apr 22, 2026 02:27PM Boston Scientific (BSX) PT Lowered to $80 at BTIG
Apr 22, 2026 06:31AM Boston Scientific (BSX) Tops Q1 EPS by 1c, Beats on Revenue; Offers FY26 EPS Guidance
Apr 21, 2026 03:09PM Boston Scientific (BSX) call put ratio 1.5 calls to 1 put as share price down 1.9%
Apr 21, 2026 09:12AM Boston Scientific (BSX) PT Lowered to $100 at Barclays
Apr 21, 2026 01:02AM Boston Scientific (BSX) PT Lowered to $85 at Stifel
Apr 18, 2026 10:00PM Q1 MedTech quarterly preview: BTIG
Apr 15, 2026 10:00AM Boston Scientific (BSX) PT Lowered to $90 at Truist
Apr 6, 2026 07:44AM Piper Sandler on BSX and MDT Following KOL Call
Apr 2, 2026 08:06AM RBC Capital on Boston Scientific (BSX): 'We Are Bullish on the LT Thesis At Current Valuations'
Mar 31, 2026 09:40AM UBS Reiterates Buy Rating on Boston Scientific (BSX)
Mar 31, 2026 05:44AM Boston Scientific (BSX) call put ratio 1.3 calls to 1 put as share price down 9%
Mar 30, 2026 10:33AM Raymond James downgrades Boston Scientific but long-term story remains intact
Mar 30, 2026 09:13AM Truist Securities Reiterates Buy Rating on Boston Scientific (BSX)
Mar 30, 2026 08:56AM RBC Capital on Boston Scientific (BSX): 'Results Point to Positive Uptake'
Mar 30, 2026 07:34AM Boston Scientific (BSX) Reiterated at Buy by Stifel After CHAMPION-AF Read-Out
Mar 30, 2026 06:45AM Boston Scientific receives FDA clearance for Asurys fluid management device
Mar 30, 2026 03:42AM Raymond James Downgrades Boston Scientific (BSX) to Outperform
Mar 27, 2026 08:21AM Bernstein Reiterates Outperform Rating on Boston Scientific (BSX)
Mar 24, 2026 06:14AM Evercore ISI adds Boston Scientific (BSX) to TAP Outperform List
Mar 24, 2026 05:26AM Stifel on Boston Scientific (BSX): 'this review adds to our optimism'
Mar 18, 2026 09:34AM Boston Scientific (BSX) PT Lowered to $92 at Truist Securities
Mar 16, 2026 04:25PM Jefferies on Boston Scientific (BSX): ICTx segment emerges as a double-digit growth engine
Mar 10, 2026 08:35AM Piper Sandler's Key Takeaways From CRT 2026
Mar 9, 2026 08:18AM Piper Sandler: 'When Will Things Turn in Med Tech and What Names to Own Now?'
Mar 4, 2026 08:37AM TD Cowen on Boston Scientific (BSX): 'We See a Valuation Disconnect at Current Prices'
Feb 6, 2026 09:30AM Boston Scientific (BSX) PT Lowered to $112 at Bernstein SocGen Group
Feb 6, 2026 08:30AM Evercore ISI Removes Boston Scientific (BSX) from TAP List
Feb 5, 2026 08:53AM Boston Scientific (BSX) PT Lowered to $115 but RBC Capital Sees Stock Reaction as a Buying Opportunity
Feb 5, 2026 07:13AM Boston Scientific (BSX) PT Lowered to $97 at Needham
Feb 5, 2026 06:20AM Oppenheimer Reiterates Outperform Rating on Boston Scientific (BSX)
Feb 5, 2026 05:56AM Boston Scientific (BSX) PT Lowered to $95 at Truist Securities
Feb 5, 2026 05:49AM Boston Scientific (BSX) PT Lowered to $112 at Canaccord Genuity
Feb 4, 2026 04:05PM Boston Scientific (BSX) PT Lowered to $110 at Stifel
Feb 4, 2026 03:01PM Boston Scientific (BSX) PT Lowered to $110 at BTIG
Feb 4, 2026 09:52AM Boston Scientific (BSX) PT Lowered to $105 at Piper Sandler, 'Buy The Dip'
Feb 4, 2026 06:31AM Boston Scientific (BSX) Tops Q4 EPS by 2c, Beats on Revenue; Offers FY26 EPS Guidance
Feb 2, 2026 09:41AM TD Cowen Reiterates Buy Rating on Boston Scientific (BSX)
Jan 26, 2026 06:05AM Evercore ISI Adds Boston Scientific (BSX) to TAP List
Jan 20, 2026 11:36AM Mizuho on Boston Scientific (BSX): 'we do not foresee any FTC risk concerns'
Jan 16, 2026 09:22AM Truist on Boston Scientific (BSX): 'PEN Acquisition To Strengthen BSX's Path Fwd'
Jan 16, 2026 08:50AM Jefferies Downgrades Penumbra (PEN) to Hold
Jan 15, 2026 01:08PM Needham Reiterates Buy Rating on Boston Scientific (BSX)
Jan 15, 2026 11:37AM Wells Fargo Downgrades Penumbra (PEN) to Equal Weight
Jan 15, 2026 09:54AM Morgan Stanley on Boston Scientific (BSX): 'Stock is looking too cheap and has clear catalysts'
Jan 15, 2026 09:53AM Stifel on Boston Scientific (BSX): 'Compelling PEN Deal Adds to Growth and Future Margin Expansion'
Jan 15, 2026 09:30AM William Blair Downgrades Penumbra (PEN) to Market Perform
View More Recent Stories View Older Stories